Covance has increased global capacity to conduct metabolite identification supporting preclinical development and early human studies. The company’s metabolite identification services now include14 senior scientists located in Madison, WI and Harrogate, UK, and an instrumentation total of five mass spectrometers, six QTrap mass spectrometers and access to nuclear magnetic resonance (NMR) analysis for unequivocal structural identification. The additions at the Madison facility were designed ac...